Companies / Croatia
Lagging Behind Regional Peers
July 2007 | BMI ViewThe Croatian market is small and behind many of its regional neighbours, including Hungary, despite its relatively advanced status. At more than 70% by value, generics - comprising mostly relatively expensive branded generics - meet the bulk of demand for pharmaceuticals, with the segment continuing to be boosted by healthcare debts, cost-containment initiatives and the support for the strong domestic generics industry in the face of distinct intellectual property (IP) deficiencies.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
